HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C
AUTOR(ES)
Grotto, Rejane Maria Tommasini
FONTE
Rev. Soc. Bras. Med. Trop.
DATA DE PUBLICAÇÃO
27/06/2019
RESUMO
Abstract INTRODUCTION: HPA polymorphism has been associated with HCV presence and fibrosis progression in chronic hepatitis C. However, it is unknown if there is an association between HPA-1 polymorphism and hepatocellular carcinoma (HCC). Therefore, this study aimed to evaluate HPA-1 polymorphism in the presence of HCC. METHODS: PCR-SSP was used to perform HPA genotyping on 76 HCV-infected patients. RESULTS: There was no association between patients with and without HCC. There was significant difference in HPA-1 genotypic frequency distribution between HCC and F1/F2 fibrosis degree. CONCLUSIONS: The HPA-1a/1b polymorphism appears to be more associated with liver damage progression than with HCC presence.
Documentos Relacionados
- Imaging technology could be useful in poor countries
- Tear fluid of hepatitis C virus carriers could be infectious.
- Could CuB be the site of redox linkage in cytochrome c oxidase?
- Chronic non-A, non-B hepatitis: role of hepatitis C virus.
- Could obesity be considered as risk factor for non-vertebral low-impact fractures?
